XML 62 R43.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements (Tables)
12 Months Ended
Sep. 30, 2021
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Financial Instruments
In accordance with the fair value hierarchy, described above, the following tables show the fair value of the Company’s financial instruments that are required to be measured at fair value as of September 30, 2021 and September 30, 2020.
Fair Value Measurements as of September 30, 2021
(Level 1)(Level 2)(Level 3)Total
(in millions)
Other Current Liabilities:
Contractual Obligations (a)$— $— $(4)$(4)
Other Noncurrent Assets:
Equity Method Investment (b)26 — — 26 
Equity Investment with Readily Determinable Fair Value (c)37 — — 37 
Other Noncurrent Liabilities:
Contractual Obligations (a)— — (15)(15)
Interest Rate Swaps (d)— (22)— (22)
Total$63 $(22)$(19)$22 

Fair Value Measurements as of September 30, 2020
(Level 1)(Level 2)(Level 3)Total
(in millions)
Other Current Liabilities:
Contractual Obligations (a)$— $— $(2)$(2)
Other Noncurrent Assets:
Equity Method Investment (b)— 47 — 47 
Other Noncurrent Liabilities:
Contractual Obligations (a)— — (4)(4)
Interest Rate Swaps (d)— (38)— (38)
Total$— $$(6)$
______________________________________
(a)This represents contingent consideration related to a fiscal 2020 acquisition. This is based on a probability weighted performance approach and it is adjusted to fair value on a recurring basis and any adjustments are typically included as a component of operating income in the consolidated statements of operations. This amount was mainly calculated using unobservable inputs such as future earnings performance of the acquiree and the expected timing of the payment.
(b)This represents an equity method investment acquired in fiscal 2019 whereby the Company has elected the fair value option under ASC 825, Financial Instruments (“ASC 825”). The valuation is based upon quoted prices in active markets.
(c)This represents an equity investment with a readily determinable fair value that was acquired and subsequently became publicly traded during the fiscal year ended September 30, 2021. The Company has measured its investment to fair value in accordance with ASC 321, Investments—Equity Securities, based on quoted prices in active markets. The Company recognized an unrealized gain on this equity investment of $17 million for the fiscal year ended September 30, 2021, which was recorded as other income in the consolidated statements of operations.
(d)The fair value of the interest rate swaps is based on dealer quotes of market forward rates and reflects the amount that the Company would receive or pay as of September 30, 2021 for contracts involving the same attributes and maturity dates.
Reconciliation of Net Liabilities Classified as Level 3
The following table reconciles the beginning and ending balances of net liabilities classified as Level 3:
Total
(in millions)
Balance at September 30, 2020$(6)
Additions(13)
Reductions— 
Payments— 
Balance at September 30, 2021$(19)